LifeWorks Northwest

Utility of DAT in Low-Risk Neonates with ABO or RhD Incompatibility

BACKGROUND Routine direct antiglobulin test (DAT) screening in newborns at risk of isoimmune hemolytic disease is a long-standing practice. Advancements in prophylactic care and noninvasive hyperbilirubinemia monitoring warrant reevaluating the value of DAT. We investigated the c...